Agilent Technologies (NYSE:A) Given New $150.00 Price Target at Wells Fargo & Company

Agilent Technologies (NYSE:AGet Rating) had its target price boosted by Wells Fargo & Company from $135.00 to $150.00 in a research note issued to investors on Tuesday morning, The Fly reports.

Several other equities analysts have also commented on the stock. Bank of America increased their target price on shares of Agilent Technologies from $148.00 to $155.00 and gave the company a buy rating in a report on Wednesday, August 17th. Robert W. Baird increased their target price on shares of Agilent Technologies from $160.00 to $170.00 in a report on Tuesday. StockNews.com started coverage on shares of Agilent Technologies in a report on Wednesday, October 12th. They set a strong-buy rating on the stock. Citigroup increased their target price on shares of Agilent Technologies from $145.00 to $150.00 and gave the company a neutral rating in a report on Tuesday. Finally, Credit Suisse Group started coverage on shares of Agilent Technologies in a report on Wednesday, August 24th. They set an outperform rating and a $165.00 target price on the stock. Four equities research analysts have rated the stock with a hold rating, nine have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of Moderate Buy and an average target price of $157.00.

Agilent Technologies Stock Performance

Shares of A stock opened at $156.86 on Tuesday. Agilent Technologies has a 12 month low of $112.52 and a 12 month high of $162.62. The company has a current ratio of 1.94, a quick ratio of 1.41 and a debt-to-equity ratio of 0.54. The stock has a market capitalization of $46.44 billion, a P/E ratio of 35.73, a PEG ratio of 2.67 and a beta of 1.06. The firm’s 50 day moving average is $133.55 and its 200 day moving average is $128.29.

Agilent Technologies (NYSE:AGet Rating) last posted its quarterly earnings data on Monday, November 21st. The medical research company reported $1.53 earnings per share for the quarter, beating the consensus estimate of $1.39 by $0.14. The firm had revenue of $1.85 billion for the quarter, compared to analysts’ expectations of $1.76 billion. Agilent Technologies had a net margin of 19.94% and a return on equity of 28.46%. The business’s quarterly revenue was up 11.4% on a year-over-year basis. During the same quarter last year, the company posted $1.21 EPS. On average, sell-side analysts anticipate that Agilent Technologies will post 5.07 earnings per share for the current year.

Agilent Technologies Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, January 25th. Stockholders of record on Tuesday, January 3rd will be paid a dividend of $0.225 per share. This is a positive change from Agilent Technologies’s previous quarterly dividend of $0.21. The ex-dividend date is Friday, December 30th. This represents a $0.90 dividend on an annualized basis and a dividend yield of 0.57%. Agilent Technologies’s payout ratio is presently 19.13%.

Insider Activity

In related news, VP Padraig Mcdonnell sold 2,506 shares of Agilent Technologies stock in a transaction dated Thursday, September 8th. The shares were sold at an average price of $134.33, for a total transaction of $336,630.98. Following the completion of the transaction, the vice president now directly owns 15,320 shares of the company’s stock, valued at approximately $2,057,935.60. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. In related news, CEO Michael R. Mcmullen sold 6,775 shares of Agilent Technologies stock in a transaction dated Wednesday, October 26th. The shares were sold at an average price of $134.43, for a total transaction of $910,763.25. Following the completion of the transaction, the chief executive officer now directly owns 191,358 shares of the company’s stock, valued at approximately $25,724,255.94. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, VP Padraig Mcdonnell sold 2,506 shares of Agilent Technologies stock in a transaction dated Thursday, September 8th. The shares were sold at an average price of $134.33, for a total transaction of $336,630.98. Following the transaction, the vice president now directly owns 15,320 shares of the company’s stock, valued at $2,057,935.60. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 35,309 shares of company stock valued at $4,846,147.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of A. Steward Partners Investment Advisory LLC raised its holdings in Agilent Technologies by 2.5% in the first quarter. Steward Partners Investment Advisory LLC now owns 6,570 shares of the medical research company’s stock worth $869,000 after buying an additional 159 shares during the last quarter. abrdn plc raised its holdings in Agilent Technologies by 5.6% in the first quarter. abrdn plc now owns 145,835 shares of the medical research company’s stock worth $19,801,000 after buying an additional 7,731 shares during the last quarter. Versor Investments LP raised its holdings in Agilent Technologies by 43.8% in the first quarter. Versor Investments LP now owns 3,020 shares of the medical research company’s stock worth $400,000 after buying an additional 920 shares during the last quarter. Shell Asset Management Co. raised its holdings in Agilent Technologies by 1.0% in the first quarter. Shell Asset Management Co. now owns 37,080 shares of the medical research company’s stock worth $4,907,000 after buying an additional 362 shares during the last quarter. Finally, Waldron Private Wealth LLC raised its holdings in Agilent Technologies by 3.3% in the first quarter. Waldron Private Wealth LLC now owns 2,927 shares of the medical research company’s stock worth $387,000 after buying an additional 93 shares during the last quarter.

Agilent Technologies Company Profile

(Get Rating)

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies.

Featured Stories

The Fly logo

Analyst Recommendations for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.